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Isoform Specific Reductions in Na+,K+-ATPase Catalytic (a)
Subunits in the Nerve of Rats with
Streptozotocin-Induced Diabetes
Abstract : Na+,K+-ATPase activity in nerve is reduced in
rats with streptozotocin-induced diabetes ; three different
isoforms of the a (catalytic) subunit of the enzyme are
present in nerve . Using western blot to determine subunit
isoform polypeptide levels in sciatic nerve, we found a
substantial reduction in al-isoform polypeptide (88% at
3 weeks, 94% at 8 weeks) after induction of diabetes by
streptozotocin . Reductions in a2 and a3 polypeptide
were smaller and not statistically significant . The reduc-
tion in amount of all three isoform polypeptides in the
nerve of 3-week diabetic animals was corrected by ad-
ministration of insulin . Accumulation of a1 polypeptide
at a nerve ligature indicated that rapid transport of that
polypeptide in nerve occurs with normal kinetics . The
results implicate a specific marked deficit in a1, much
more than a2 or a3, catalytic subunit isoform of Na+,K+-
ATPase in the pathogenesis of diabetic neuropathy. Key
Words : Na,K-transporting ATPase-Diabetes -Axonal
transport-Nerve .
J . Neurochem. 63,1782-1786 (1994) .
Neuropathy is a common and often disabling com-
plication of diabetes (Greene et al ., 1988) . In rat and
rabbit models of acute diabetes, activity of Na+ ,K+ -
ATPase measured in the nerve is substantially reduced
(Das et al ., 1976 ; Greene and Lattimer, 1983, 1984;
Greene et al ., 1984) . The kinetic defect in enzyme
activity can be reversed in part by ganglioside treat-
ment in vivo (Bianchi et al ., 1988) or by protein kinase
C agonists in vitro (Greene and Lattimer, 1986), but
the pathogenetic mechanism underlying the defect in
Na+,K+-ATPase activity remains obscure .
The functional Na+,K+-ATPase enzyme is a hetero-
dimer composed of an a (Mr 112,000) and a 0 (Mr
35,000) subunit in 1:1 stoichiometry (Cantley, 1981) .
The a subunit contains the catalytic site for the ex-
change of three Na' for two K+ , in addition to the
ATP and ouabain binding sites (Shull et al ., 1986 ;
Lingrel et al ., 1990) . In the nervous system, three dif-
ferent isoforms of the a subunit, termed al, a2, and
a3, are expressed as the products of three distinct
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members of a multigene family (Shull et al ., 1986 ;
Herrera et al ., 1987) . These isoforms can be character-
ized by isoform-specific pharmacologic properties
(Sweadner, 1985, 1989; Shyjan et al ., 1990 ; Jewell and
Lingrel, 1991), suggesting that there may be isoform-
specific functions in cells of the nervous system. The
,6 subunit has not been shown to participate in the
catalytic function of the sodium pump but may be
required for the transport and insertion of functional
a,6 heterodimers into the membrane (McDonough et
al ., 1990 ; Geering, 1991) . Two isoforms of the)3 sub-
unit have been identified in mammals .
The development of isoform-specific RNA and
polypeptide probes has allowed investigation of the
distribution of individual isoforms in the nervous sys-
tem. Each of the a isoform mRNAs has a specific
regional and cellular distribution (Filuk et al ., 1989 ;
Hieber et al ., 1991 ; Mata et al ., 1991c; Watts et al .,
1991), and a corresponding distribution of isoform
polypeptides can be defined by western blot (Shyjan
and Levenson, 1989) and by immunocytochemistry
(McGrail et al ., 1991) . mRNAs coding for the a iso-
forms are found in motor neuron cell bodies in the
spinal cord and in the dorsal root ganglia (DRG) (Mata
et al ., 1991c) . al and a2 mRNAs are found in Schwann
cells of the peripheral nerve (Mata et al ., 1991b,c) . All
three isoform polypeptides are present in the nerve by
western blot (Mata et al ., 1993) .
To determine whether, in acute diabetes (1) the de-
fect in Na+,K+-ATPase activity in nerve reflects a re-
duction in the amount of polypeptide and (2) whether
such defects are isoform specific, we used a quantita-
tive western blot analysis to determine the levels of
each of the three isoform polypeptides in the sciatic
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Na',K+-ATPase a ISOFORMS IN STZ-DIABETIC RAT NERVE
FIG . 1 . Quantitative western blot . Western blot with the a1 anti-
body of total nerve homogenate, detected using Luminol and
quantitated by integrated densitometry of the film .




Adult male Sprague-Dawley rats (230-290 g at the time
of injection) were rendered diabetic by intraperitoneal injec-
tion of STZ. There were three surviving animals in each
diabetic and control group, except as indicated. All diabetic
rats had randomly obtained blood glucose values in excess
of 400 mg/dl measured weekly until the time they were
killed . The body weight of the diabetic rats decreased
throughout the experiment . The diabetic animals used for
studies of Na',K+-ATPase isoform polypeptide levels aver-
aged 205 g at 1 week, 167 g at 3 weeks, and 150 g at 8
weeks of diabetes, compared with simultaneous controls that
weighed 285 g at 1 week, 330 g at 3 weeks, and 375 g at 8
weeks. The 3-week diabetic animals used in studies ofaxonal
transport averaged 155 g at 3 weeks compared with simulta-
neous controls that averaged 380 g at 3 weeks.
To control for direct toxic effects of STZ, one set of
animals was treated with NPH (isophane suspension) insulin
5 days of7 for 3 weeks after induction ofdiabetes . Treatment
was begun with 2 units each morning and 4 units each eve-
ning subcutaneously, and the dose increased based on ran-
domly timed blood glucose determinations performed daily;
these random glucose measurements were all <210 mg/dl.
Two of the five treated animals died during the course of
treatment, presumably from hypoglycemia . The average
weight of the surviving animals increased from 240 g at
induction of diabetes to 320 g at 3 weeks, compared with
controls that increased from 250 g to 360 g over a similar
time course .
All animal treatments adhered strictly to all institutional
and national ethical guidelines .
Ligature experiment
The animals were anesthetized with chloral hydrate, the
sciatic nerve exposed in the gluteal region, and a ligature of
4-0 prolene tied tightly around the nerve. Twenty-four hours
later the animals were killed by decapitation, the nerve was
cut into consecutive 3-mm segments both proximal and distal
to the ligature, and was homogenized in 50 rnM Tris, 5 mM
NaCl, pH 7, and 25 mg of homogenate protein analyzed for
al polypeptide by western blot as described below.
Protein preparation
The rats were killed by decapitation . Rapidly dissected
sciatic nerves were homogenized in 50 rnM Tris, 5 rnM
NaCl, and centrifuged at 10,000 rpm for 15 min to remove
debris . Acrude membrane fraction was separated from solu-
ble proteins by centrifugation at 100,000 g for 1 h in a
Beckman Airfuge. We have shown previously that all of
the immunoreactive Na',K'-ATPase polypeptide in nerve is
found in this crude membrane fraction (Mata et al ., 1991 a) .
Western blot
Ten micrograms of nerve membrane protein was separated
by 6% polyacylamide gel electrophoresis (Laemmli, 1970)
and the proteins transferred to a nitrocellulose membrane
(Hybond-ECL) as described (Towbin et al ., 1979). The blots
were blocked in 5% dried milk in Tris-buffered saline-Twenn
for 2 h and incubated overnight with commercially obtained
isoform specific anti-a-isoform antibodies (Upstate Bio-
technologies, Inc.) raised against fusion proteins at a dilution
of 1 :1,000 . The specificities of these antibodies in western
blot have previously been demonstrated (Shyjan and Leven-
son, 1989). After washing, the blots were incubated with
peroxidase-conjugated affinity-purified goat anti-rabbit IgG
(Cappel) at 1 :3,000 for 1 h, followed by reaction with Lumi-
nol (Amersham) for 1 min. The reacted blots were exposed
to Hyperfilm-ECL for times ranging from 1 to 10 min. The
samples to be compared quantitatively were all placed on a
single gel and reacted together .
Quantitation
The amount of immunoreactive polypeptide was quanti-
tated by integrated densitometric analysis of the film using a
PC-based image analysis system (MCID, Imaging Resources
Inc.). The Luminol method allows quantitative determination
of immunoreactive polypeptide (Young et al ., 1991), and we
confirmed that using this method, the measurement of a
isoform polypeptide in nerve is linear over the range of
concentrations found in a 3-mm nerve segment (Fig . 1) . The
statistical significance of differences was determined by two-
tail t test .
RESULTS
Western blot of membrane fractions isolated from
nerve confirmed the presence of all three a-isoform
polypeptides in control nerve (Fig . 2, first lane). Previ-
ous in situ hybridization studies have shown that al,
FIG . 2 . al-Isoform polypeptide
levels are markedly reduced in the
sciatic nerve of STZ-diabetic rats .
At 1, 3, and 8 weeks of diabetes
the amount of isoform-specific
polypeptide in nerve of control (C)
and diabetic (D) rats was deter-
mined by western blot with mono-
clonal antibodies specific for al,
a2, and a3 isoforms of Na',K'-
ATPase . Each lane contains 15 hg
of membrane fraction protein .
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FIG. 3. Quantitative analysis of a-isoform polypeptide levels in
nerve of diabetic and treated animals. The amount of polypeptide
from each nerve segmentwas quantified by integrated densitom-
etry of the film . The data are presented as the ratio of diabetic
to age-matched controls at each time point. *p < 0.01, com-
pared with control animals. The insulin-treated animals were sig-
nificantly different both from the untreated 3-week diabetic ani-
mals and from control animals (p < 0.01) . None of the other
apparent differences are statistically significant.
a2, and a3 mRNAs are present in the sensory neurons
of the DRG and the motor neurons of the ventral horn
of spinal cord (Mata et al ., 1991c, and authors' unpub-
lished data) . Both al and a2, but not a3, mRNAs are
present in the nerve, where virtually all the mRNA is
located in Schwann cells (Mata et al ., 1991c) .
After 1 week of STZ-induced diabetes, there was a
slight reduction in the amount of al-immunoreactive
polypeptide in sciatic nerve . By 3 weeks of diabetes,
a l polypeptide was markedly reduced in nerve and
was barely detectable at 8 weeks of diabetes (Fig . 2,
top row) . Levels of a2-polypeptide immunoreactivity
in nerve appeared unchanged at 1 week of diabetes,
and slightly reduced at 3 and 8 weeks of diabetes (Fig .
2, second row) . a3-Polypeptide immunoreactivity in
contrast was unchanged at 1 week, mildly reduced at
3 weeks, but appeared normal after 8 weeks of diabetes
(Fig . 2, third row) . Quantitative analysis by integrated
densitometry of the western blot showed that al-poly-
peptide levels were reduced to 12% of control after 3
weeks of diabetes and only 6% of control at 8 weeks
of diabetes (Fig . 3) . These results were statistically
significant (p < 0.01) . a2 was reduced -50% at 3
and 8 weeks of diabetes, and a3 was reduced -50%
at 3 weeks of diabetes but recovered to -75% at 8
weeks . These changes at 8 weeks were not statistically
significant (Fig . 3) .
Treatment of STZ-induced diabetes with insulin, be-
ginning 24 h after STZ injection, corrected the loss of
al-immunoreactive polypeptide in nerve at 3 weeks of
diabetes (Fig . 4) . In these treated animals with random
glucose levels <210 mg/dl, the weight gain was near
but not quite normal . Quantitative analysis showed that
the amount of al polypeptide was corrected to -50%
of normal, which was significantly different both from
the 3-week untreated diabetic animals and from the
controls (Fig . 3) . The amount of a2 and a3 polypep-
tides in the treated animals was essentially normal .
Because al isoform is found in Schwann cells and
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FIG. 4. Insulin treatment prevents
the reduction in a1 isoform after
3 weeks of diabetes . Rats were
treated with insulin beginning 24
h after injection of STZ and killed
at 3 weeks after injection . The
amount of a1 polypeptide in the
nerve of two control and three in-
sulin-treated diabetic animals is
shown. Each lane contains 15 Fig
of membrane fraction protein.
fibroblasts in addition to neurons, it was important to
determine whether the immunoreactive a 1 polypeptide
in the STZ-diabetic animals was neuronal or Schwann
cell in origin . We have previously shown that al-iso-
form polypeptide ATPase is carried into the nerve by
rapid axonal transport and consequently accumulates
at a ligature placed on the nerve (Mata et al ., 1993) .
When a ligature was placed on the sciatic nerve, and
accumulation of transported polypeptide allowed to
proceed for 24 h, a l polypeptide accumulated at the
ligature in both normal and diabetic animals (Fig . 5),
indicating normal kinetics of axonal transport of the
immunoreactive polypeptide . The amount of immuno-
reactivity was less in the diabetic than in the control
animals both in the segments proximal to the ligature
as well as in the segment immediately adjacent to the
ligature in which the accumulation occurred . A quanti-
tative comparison of this reduction was not obtained,
because the samples were run on different gels .
DISCUSSION
This is the first description of a disease process af-
fecting the nervous system in adult animals in which
differential effects on isoforms of the catalytic subunit
of Na+,K+-ATPase a subunit have been found . Thy-
roid hormone regulates Na+,K+-ATPase isoform gene
expression in a variety of tissues during development
(Gick et al ., 1988 ; McDonough et al ., 1988 ; Orlowski
and Lingrel, 1990 ; Melikian and Ismail Beigi, 1991),
and affects the abundance of Na+,K+-ATPase during
development in neonatal rat brain (Schmitt and McDo-
nough, 1988), but does not appear to affect Na+,K+-
ATPase abundance or activity in the brain of adult
animals (Lin and Akera, 1978; Horowitz et al ., 1990) .
FIG. 5. a1 is carried by rapid axo-
nal transport in normal and dia-
betic rats . Twenty-four hours after
sciatic nerve ligature, the amount
of a1-immunoreactive polypep-
tide in consecutive 3-mm seg-
ments of the nerve was deter-
mined by western blot . a1 accu-
mulates proximal to the ligature in
both the normal and diabetic
nerve. Each lane represents the protein from one segment, and
the third lane is the segment just proximal to the ligature . The
experiment was repeated twice.
Na+,K+-ATPase a ISOFORMS IN STZ-DIABETIC RAT NERVE
In vitro, Na+,K+-ATPase gene expression is also regu-
lated by the ionic composition ofthe extracellular envi-
ronment (Pressley et al ., 1988 ; Taormino and Fam-
brough, 1990) and by glucocorticoids (Pressley, 1988 ;
Bhutada et al., 1991 ; Celsi et al., 1991) .
Substantial evidence implicates deficits in Na+,K+ -
ATPase activity in nerve in the pathogenesis of dia-
betic neuropathy (Greene and Winegrad, 1981 ; Greene
and Lattimer, 1984 ; Greene et al ., 1988) . Whereas the
exact role of this metabolic defect in the pathogenesis
of the neuropathy is not yet clear, evidence suggests
that it is an important step in the development ofphysi-
ologic and structural correlates of diabetic neuropathy.
Direct determination of Na+,K+-ATPase pump con-
centration in peripheral nerve of STZ-diabetic rats by
;H]ouabain binding showed a 16% reduction after 4
weeks of diabetes . In that study the binding appeared
to occur to only a single population of sites, with an
apparent KD of 2.2 x 10-6 M (Kjeldsen et al ., 1987) .
The western blot data of the current study indicate
that all three isoform polypeptides are found in the
peripheral nerve, but only a l is significantly reduced
in the diabetic animals . More recently, a 10-30% de-
crease in Na+,K+-ATPase enzymatic activity in differ-
ent regions ofbrain in STZ-diabetic rats has been found
(Leung and Leung, 1991), with no alteration in other
enzymes of the glucose metabolic pathway .
The ligature experiments further indicate that most
of the Na+ ,K+-ATPase al polypeptide detected in
nerve is synthesized at the neuronal cell body and
transported into the axon, despite the potentially con-
founding observation that Schwann cells also express
a 1 mRNA (Hieber et al ., 1991) and polypeptide (Shy-
jan and Levenson, 1989) . We have previously shown
that all neurons in the spinal cord and in the DRG
express a3 mRNA, with some of those neurons coex-
pressing high amounts of al mRNA (Mata et al .,
1991 c) . Whether neurons that in normal conditions ex-
press high amounts of al become selectively impaired
in diabetic neuropathy is not known .
What is the significance of the relatively selective
loss of al isoform from the axolemma? Voltage clamp
analysis of the node of Ranvier in diabetic rats has
shown an elevation in intraaxonal Na' (Sima and
Brismar, 1985; Brismar et al ., 1987), which correlates
with the reduction in nerve Na+,K+-ATPase . The re-
sults of the current study suggest that the al isoform
may be responsible for Na+,K+ exchange at the node
of Ranvier . We have recently shown, by quantitative
in situ hybridization, that in response to increased elec-
trical activity induced by salt treatment, the neurons
of the supraoptic and paraventricular nuclei of the hy-
pothalamus increase the amount of al but not a2 or
a3 mRNA (Mata et al ., 1992) . This finding led us
to propose that in those cells al isoform might be
specifically involved in exchanging Na', which en-
tered through voltage-gated channels during electrical
depolarization at the neuron terminal . These two exper-
iments taken together suggest that al isoform may
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function specifically at the node and the terminal where
the major Na' fluxes occur .
Ongoing studies will define whether the deficit in
a 1 occurs at the level of transcription or translation or
represents a posttranslational effect.
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